ATE395428T1 - Verfahren zur isolierung und reinigung von lipidezellwandkomponenten - Google Patents

Verfahren zur isolierung und reinigung von lipidezellwandkomponenten

Info

Publication number
ATE395428T1
ATE395428T1 AT96903143T AT96903143T ATE395428T1 AT E395428 T1 ATE395428 T1 AT E395428T1 AT 96903143 T AT96903143 T AT 96903143T AT 96903143 T AT96903143 T AT 96903143T AT E395428 T1 ATE395428 T1 AT E395428T1
Authority
AT
Austria
Prior art keywords
derivatives
salts
mycolic acids
lipide
isolation
Prior art date
Application number
AT96903143T
Other languages
English (en)
Inventor
Jan Verschoor
Original Assignee
Adcock Ingram Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Adcock Ingram Ltd filed Critical Adcock Ingram Ltd
Application granted granted Critical
Publication of ATE395428T1 publication Critical patent/ATE395428T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/04—Mycobacterium, e.g. Mycobacterium tuberculosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1267—Gram-positive bacteria
    • C07K16/1289—Mycobacteriaceae (F)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/5695—Mycobacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
    • Y02E50/00—Technologies for the production of fuel of non-fossil origin
    • Y02E50/10—Biofuels, e.g. bio-diesel

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicinal Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Pulmonology (AREA)
  • Communicable Diseases (AREA)
  • Food Science & Technology (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
AT96903143T 1995-02-22 1996-02-22 Verfahren zur isolierung und reinigung von lipidezellwandkomponenten ATE395428T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ZA951464 1995-02-22

Publications (1)

Publication Number Publication Date
ATE395428T1 true ATE395428T1 (de) 2008-05-15

Family

ID=25584852

Family Applications (1)

Application Number Title Priority Date Filing Date
AT96903143T ATE395428T1 (de) 1995-02-22 1996-02-22 Verfahren zur isolierung und reinigung von lipidezellwandkomponenten

Country Status (12)

Country Link
US (1) US6171830B1 (de)
EP (1) EP0811075B1 (de)
JP (1) JPH11500906A (de)
CN (1) CN1183811A (de)
AT (1) ATE395428T1 (de)
AU (1) AU720288B2 (de)
CA (1) CA2213428A1 (de)
DE (1) DE69637522D1 (de)
HU (1) HUP9900378A3 (de)
RU (1) RU2155230C2 (de)
WO (1) WO1996026288A1 (de)
ZA (1) ZA961412B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPO359396A0 (en) 1996-11-13 1996-12-05 Amrad Operations Pty. Limited A method of treatment and pharmaceutical compositions useful for same
AU726734B2 (en) * 1996-11-13 2000-11-16 Centenary Institute Of Cancer Medicine & Cell Biology Mycobacterium cell wall compositions
CN1057077C (zh) * 1998-05-12 2000-10-04 中国医学科学院医药生物技术研究所 一种具有免疫抑制作用的化合物
CN102834716B (zh) 2010-02-23 2016-03-30 华盛顿大学 人工分枝菌酸膜
PL2661253T3 (pl) * 2011-01-04 2017-08-31 Archivel Farma, Sl Preparat liposomowy odpowiedni do leczenia lub zapobiegania gruźlicy
DK2802345T3 (en) 2012-01-12 2018-04-30 Archivel Farma Sl MTB-C-VACCINE AGAINST ALLERGIC REACTIONS

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877612A (en) * 1985-05-20 1989-10-31 Frank M. Berger Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
WO1987005606A1 (fr) * 1986-03-20 1987-09-24 Sawai Pharmaceutical Co., Ltd. TRIMYCOLATE DE alpha, alpha-TREHALOSE ET COMPOSITION MEDICINALE
EP0751780B1 (de) 1993-06-21 2003-09-03 Brigham And Women's Hospital Verfahren zur isolierung von cda-präsentierten antigenen, cd1-präsentierte antigeneenthaltende impfstoffe und in besagten verfahren verwendbare zelllinien
NZ283784A (en) * 1994-04-14 1998-08-26 Adcock Ingram Ltd Diagnostic assay for mycobacterium and intracellular antigen

Also Published As

Publication number Publication date
WO1996026288A1 (en) 1996-08-29
AU4728796A (en) 1996-09-11
JPH11500906A (ja) 1999-01-26
RU2155230C2 (ru) 2000-08-27
ZA961412B (en) 1996-08-26
US6171830B1 (en) 2001-01-09
CA2213428A1 (en) 1996-08-29
DE69637522D1 (de) 2008-06-26
HUP9900378A2 (hu) 1999-05-28
AU720288B2 (en) 2000-05-25
HUP9900378A3 (en) 1999-11-29
EP0811075B1 (de) 2008-05-14
CN1183811A (zh) 1998-06-03
EP0811075A1 (de) 1997-12-10

Similar Documents

Publication Publication Date Title
DE69427357D1 (de) Verfahren zur herstellung von zusammensetzungen zur reinigung von halbleiterverfahrensgasen zur entfernung von lewis-säure und oxydationsmittelverunreinigungen
DE59608686D1 (de) Verfahren zur Entfernung von unerwünschten lipophilen Verunreinigungen und/oder Rückständen, welche in Getränken oder pflanzlichen Zubereitungen enthalten sind
DE59409712D1 (de) Verfahren zur chromatographischen reinigung und trennung von nucleinsäuregemischen
ATE88442T1 (de) Verfahren zur trennung von zucker und konzentrierter schwefelsaeure.
ATE208399T1 (de) Ein verfahren zur reinigung von phosphatidylserin
ATE202356T1 (de) Extraktives verfahren zur gewinnung von natürlichen makroliden
DE60001173D1 (de) Verfahren zum extrahieren und reinigung von paclitaxel aus natürlicher quelle
SE8402861D0 (sv) Rening av biologiskt material
ATE395428T1 (de) Verfahren zur isolierung und reinigung von lipidezellwandkomponenten
DE68900939D1 (de) Entfernung von sauren verunreinigungen in einem loesungsmittelextraktionsverfahren zur trennung von aromaten von nichtaromaten.
ATE289289T1 (de) Verfahren zur reinigung von alkanolaminen
ATE33014T1 (de) Verfahren zur reinigung von nassverfahrensphosphorsaeure.
ATE2194T1 (de) Verfahren zur gegenstromkristallisation.
ATE147066T1 (de) Verfahren zum abtrennen von aminosäuren aus wässrigen lösungen
ATE201387T1 (de) Verfahren zur reinigung von weissen phosphor
ATE72756T1 (de) Verfahren zur herstellung eines biologischen stoffes.
FR2374263A1 (fr) Procede de purification de l'acide phosphorique prepare par voie humide
DE59903651D1 (de) Verfahren zur herstellung von [15 o]butanol und vorrichtung zur durchführung des verfahrens
DE68928249D1 (de) Verfahren zur Trennung von Methylester von alpha-L-aspartyl-L-phenylalaninen
DE59407510D1 (de) Verfahren zur Trennung und Reinigung von Stoffen durch Schmelzkristallisation unter hohen Drücken
ATE341562T1 (de) Verfahren zur darstellung von lh-rh-derivaten
ZA881569B (en) Method for removing organic materials dissolved in purified phosphoric acid
DE3763068D1 (de) Verfahren zur abtrennung und reinigung organischer substanzen von begleitstoffen.
ATE196855T1 (de) Verfahren und vorrichtung zur phasenseparation
MX9604805A (es) Proceso para separar sulfona de una corriente de hidrocarburo para proporcionar un producto de sulfona seco.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties